002044.SZ
美年健康
SZSE · Healthcare · Q 卫生 · CN
CNY 4.61
−1.71%Year over year
Reported trailing growth
- Revenue
- -4.4%
- EBITDA
- —
- EBIT
- +5.1%
- EPS
- -50.9%
- Free cash flow
- +8.4%
- Operating cash flow
- +1.3%
Forward estimates
Based on analyst estimates
- Revenue
- +20.1%
- EBITDA
- +157.9%
- EPS
- +668.4%
Three-year CAGR
- Revenue
- +6.3%
- EBITDA
- +66.0%
- EBIT
- -17.8%
- Net income
- -24.9%
- EPS
- -26.6%
- Free cash flow
- +7.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026